Ye Bi

1.2k total citations · 2 hit papers
18 papers, 849 citations indexed

About

Ye Bi is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Ye Bi has authored 18 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomaterials, 7 papers in Molecular Biology and 5 papers in Biomedical Engineering. Recurrent topics in Ye Bi's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Ye Bi is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Ye Bi collaborates with scholars based in China, United States and Malaysia. Ye Bi's co-authors include Lesheng Teng, Robert J. Lee, Jing Xie, Shiyan Dong, Huan Zhang, Zhaogang Yang, Yating Sun, Lu Fu, Yarong Zhao and Zhidong Qiu and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and Small.

In The Last Decade

Ye Bi

17 papers receiving 842 citations

Hit Papers

Cell-Penetrating Peptides in Diagnosis and Treatment of H... 2020 2026 2022 2024 2020 2025 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
    2020 339 citations Jing Xie, Ye Bi et al. Frontiers in Pharmacology profile →
  2. Precise nanoscale fabrication technologies, the “last mile” of medicinal development
    2025 23 citations Ye Bi, Ziwei Li et al. Acta Pharmaceutica Sinica B profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Bi China 14 525 265 191 91 80 18 849
Ergang Liu China 18 517 1.0× 307 1.2× 256 1.3× 138 1.5× 49 0.6× 44 1.1k
Rohan Lalani India 16 263 0.5× 221 0.8× 108 0.6× 160 1.8× 35 0.4× 21 605
Chantal C.M. Appeldoorn Netherlands 16 550 1.0× 339 1.3× 146 0.8× 126 1.4× 24 0.3× 22 976
Qing Shen China 16 572 1.1× 282 1.1× 161 0.8× 29 0.3× 28 0.3× 34 904
Manfei Fu China 11 276 0.5× 254 1.0× 150 0.8× 96 1.1× 33 0.4× 16 652
Sunhui Chen China 11 329 0.6× 210 0.8× 169 0.9× 98 1.1× 24 0.3× 19 591
Paolo Gasco Italy 17 595 1.1× 279 1.1× 139 0.7× 230 2.5× 22 0.3× 32 1.1k
Prarthana Rewatkar Australia 16 364 0.7× 191 0.7× 147 0.8× 144 1.6× 17 0.2× 23 867
Yongwei Gu China 16 535 1.0× 201 0.8× 272 1.4× 219 2.4× 30 0.4× 30 1.0k
Linglin Feng China 15 411 0.8× 393 1.5× 259 1.4× 146 1.6× 15 0.2× 26 831

Countries citing papers authored by Ye Bi

Since Specialization
Citations

This map shows the geographic impact of Ye Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Bi more than expected).

Fields of papers citing papers by Ye Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Bi. The network helps show where Ye Bi may publish in the future.

Co-authorship network of co-authors of Ye Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Bi. A scholar is included among the top collaborators of Ye Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Bi. Ye Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Teng, Lesheng, et al.. (2025). Nano-oncology revisited: Insights on precise therapeutic advances and challenges in tumor. Fundamental Research. 5(5). 1845–1859. 5 indexed citations
2.
Li, Ziwei, Yue Zhang, Haifeng Tang, et al.. (2025). A transdermal drug delivery system based on estradiol liposomes enhances the alleviation of psoriatic skin inflammation. International Journal of Pharmaceutics. 685. 126234–126234.
3.
Bi, Ye, et al.. (2025). Precise nanoscale fabrication technologies, the “last mile” of medicinal development. Acta Pharmaceutica Sinica B. 15(5). 2372–2401. 23 indexed citations breakdown →
4.
Dong, Shiyan, Ye Bi, Xiangshi Sun, et al.. (2022). Dual‐Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple‐Negative Breast Cancer. Small. 18(16). e2107690–e2107690. 44 indexed citations
5.
Teng, Lesheng, et al.. (2021). Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy. International Journal of Nanomedicine. Volume 16. 1525–1551. 99 indexed citations
6.
Xie, Jing, Ye Bi, Huan Zhang, et al.. (2020). Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application. Frontiers in Pharmacology. 11. 697–697. 339 indexed citations breakdown →
7.
Bi, Ye, et al.. (2020). A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine. Molecules. 25(2). 338–338. 23 indexed citations
8.
Bi, Ye, Robert J. Lee, Jing Xie, et al.. (2019). Liposomal Vitamin D3 as an Anti-aging Agent for the Skin. Pharmaceutics. 11(7). 311–311. 50 indexed citations
9.
Zhao, Yarong, Shiyan Dong, Yating Sun, et al.. (2018). Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood–Brain Barrier. Anticancer Research. 39(1). 237–243. 41 indexed citations
10.
Bi, Ye, Robert J. Lee, Yating Sun, et al.. (2018). Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy. International Journal of Nanomedicine. Volume 13. 5811–5822. 16 indexed citations
11.
Sun, Yating, Yarong Zhao, Huan Zhang, et al.. (2018). Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy. International Journal of Nanomedicine. Volume 14. 135–148. 57 indexed citations
12.
Bi, Ye, Yulin Zhou, Mengqiao Wang, et al.. (2017). Targeted Delivery of Cordycepin to Liver Cancer Cells Using Transferrin-conjugated Liposomes. Anticancer Research. 37(9). 5207–5214. 23 indexed citations
13.
Liu, Zongyu, Ye Bi, Yating Sun, et al.. (2017). Pharmacokinetics of a liposomal formulation of doxorubicin in rats. Saudi Pharmaceutical Journal. 25(4). 531–536. 15 indexed citations
14.
Wang, Mengqiao, Robert J. Lee, Ye Bi, et al.. (2017). Transferrin-conjugated liposomes loaded with novel dihydroquinoline derivatives as potential anticancer agents. PLoS ONE. 12(10). e0186821–e0186821. 7 indexed citations
15.
Li, Yuhuan, Robert J. Lee, Kongtong Yu, et al.. (2016). Delivery of siRNA Using Lipid Nanoparticles Modified with Cell Penetrating Peptide. ACS Applied Materials & Interfaces. 8(40). 26613–26621. 52 indexed citations
16.
Zheng, Bin, Lirong Teng, Ye Bi, et al.. (2015). Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats. European Journal of Pharmaceutical Sciences. 77. 254–264. 33 indexed citations
17.
18.
Zheng, Bin, Shuang Yang, Ye Bi, et al.. (2015). Oleic acid derivative of polyethylenimine-functionalized proliposomes for enhancing oral bioavailability of extract of Ginkgo biloba. Drug Delivery. 23(4). 1194–1203. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ergang Liu Breakdown of academic impact, for papers by Rohan Lalani Breakdown of academic impact, for papers by Chantal C.M. Appeldoorn Breakdown of academic impact, for papers by Qing Shen Breakdown of academic impact, for papers by Manfei Fu Breakdown of academic impact, for papers by Sunhui Chen Breakdown of academic impact, for papers by Paolo Gasco Breakdown of academic impact, for papers by Prarthana Rewatkar Breakdown of academic impact, for papers by Yongwei Gu Breakdown of academic impact, for papers by Linglin Feng
Rankless by CCL
2026